The Trader Harbor
  • Business
  • Politics
  • World News
  • Stocks
  • Business
  • Politics
  • World News
  • Stocks

The Trader Harbor

World News

McKinsey & Co. to pay $650M to settle opioid consulting probe, ex-partner to plead guilty

by admin December 19, 2024
December 19, 2024
McKinsey & Co. to pay $650M to settle opioid consulting probe, ex-partner to plead guilty

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company’s consulting work advising Purdue Pharma on how to increase sales of its opioid painkiller OxyContin, a court filing said Friday.

A former top partner at McKinsey, Martin Elling, also agreed to plead guilty to obstruction of justice next month in the probe by the U.S. Department of Justice, according to a filing in U.S. District Court in Abingdon, Virginia.

The criminal charging document that McKinsey agreed to have filed by prosecutors alleges the consulting giant “knowingly and intentionally” conspired with Purdue Pharma “and others to aid and abet the misbranding of prescription drugs.”

The document also said McKinsey is accused, through the acts of its then-partner Elling, of “knowingly destroying and concealing records and documents with the intent” to impede the investigation by the Department of Justice.

McKinsey, which previously agreed to pay almost $1 billion to settle lawsuits by states, local governments and others related to its opioid consulting, accepted responsibility for the conduct alleged by federal prosecutors, according to the deferred prosecution agreement.

As part of the deal, McKinsey will not work on any marketing, sale, promotion or distribution of controlled substances.

In a statement to CNBC, McKinsey said, “We are deeply sorry for our past client service to Purdue Pharma and the actions of a former partner who deleted documents related to his work for that client.”

“We should have appreciated the harm opioids were causing in our society and we should not have undertaken sales and marketing work for Purdue Pharma,” the firm said. “This terrible public health crisis and our past work for opioid manufacturers will always be a source of profound regret for our firm has requested comment from McKinsey.”

The company said that in addition to its deferred prosecution agreement with the DOJ, it “has agreed to settle a related civil False Claims Act investigation and to enter into a Corporate Integrity Agreement with the Office of Inspector General at the Department of Health and Human Services.”

This post appeared first on NBC NEWS

0
FacebookTwitterGoogle +Pinterest
previous post
Grubhub to pay $25M to settle charges that it misled diners and drivers about costs and pay
next post
How Trump could spare Biden’s renewable energy credits and still cripple his landmark climate bill

Related Posts

Amazon and Nvidia say AI data center demand...

April 25, 2025

Some experts have raised the odds of a...

August 15, 2024

China opens probe into Nvidia, accusing company of...

December 11, 2024

UnitedHealth says it faces DOJ investigation over Medicare...

July 25, 2025

Amazon plans to give Alexa an AI overhaul...

May 23, 2024

Tesla’s affordability push eases growing doubts about its...

April 24, 2024

Mattel says Barbies and Hot Wheels could soon...

February 6, 2025

WNBA files trademark application to bring back ‘Detroit...

February 2, 2025

Goodbye to ‘bags fly free’ on Southwest Airlines,...

March 17, 2025

Peloton CEO Barry McCarthy to step down, company...

May 3, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Latest

    • China outlines more controls on exports of rare earths and technology

      October 11, 2025
    • The Real Drivers of This Market: AI, Semis & Robotics

      October 11, 2025
    • S&P 500 Breaking Out Again: What This Means for Your Portfolio

      October 11, 2025
    • White House turns to expanding Abraham Accords after Israel-Hamas ceasefire

      October 11, 2025
    • Georgia’s Mike Collins needles Ossoff in new ad over shutdown’s toll on airports, workers

      October 11, 2025
    • Bondi announces arrest of ‘coward’ who allegedly threatened conservative influencer following Kirk’s murder

      October 11, 2025

    Categories

    • Business (1,417)
    • Politics (4,710)
    • Stocks (1,701)
    • Uncategorized (45)
    • World News (1,410)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: TheTraderHarbor, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2025 thetraderharbor.com | All Rights Reserved